224 related articles for article (PubMed ID: 33305708)
1. State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure.
Al-Sadawi M; Ortega RR; Ariyaratnam J; Battisha A; Madoukh B; Bukharovich I
Curr Cardiol Rev; 2021; 17(5):e230421189012. PubMed ID: 33305708
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
5. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
[TBL] [Abstract][Full Text] [Related]
6. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
[TBL] [Abstract][Full Text] [Related]
7. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
[TBL] [Abstract][Full Text] [Related]
8. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
[TBL] [Abstract][Full Text] [Related]
9. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
[TBL] [Abstract][Full Text] [Related]
10. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
[TBL] [Abstract][Full Text] [Related]
11. Device-based treatment options for heart failure with preserved ejection fraction.
Miyagi C; Miyamoto T; Karimov JH; Starling RC; Fukamachi K
Heart Fail Rev; 2021 Jul; 26(4):749-762. PubMed ID: 33432418
[TBL] [Abstract][Full Text] [Related]
12. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction.
Riccardi M; Tomasoni D; Vizzardi E; Metra M; Adamo M
Heart Fail Rev; 2023 Mar; 28(2):315-330. PubMed ID: 36402928
[TBL] [Abstract][Full Text] [Related]
13. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
[TBL] [Abstract][Full Text] [Related]
14. Interatrial Shunt Devices.
Salah HM; Baratto C; Yaranov DM; Rommel KP; Achanta S; Caravita S; Reddy Vasanthu VK; Fudim M
Heart Fail Clin; 2024 Jan; 20(1):61-69. PubMed ID: 37953022
[TBL] [Abstract][Full Text] [Related]
15. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction.
Nanayakkara S; Kaye DM
Heart Fail Rev; 2023 Mar; 28(2):281-286. PubMed ID: 35438418
[TBL] [Abstract][Full Text] [Related]
16. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
[TBL] [Abstract][Full Text] [Related]
17. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
[TBL] [Abstract][Full Text] [Related]
18. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
De Rosa R; Schranz D
Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
[TBL] [Abstract][Full Text] [Related]
19. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
[TBL] [Abstract][Full Text] [Related]
20. Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Rosalia L; Ozturk C; Shoar S; Fan Y; Malone G; Cheema FH; Conway C; Byrne RA; Duffy GP; Malone A; Roche ET; Hameed A
JACC Basic Transl Sci; 2021; 6(9-10):772-795. PubMed ID: 34754993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
